Middlemen Who Save $$ On Medicines — But Maybe Not For You
Published by Kaiser Health News
Pharmacy benefit managers — companies that are often unnoticed and even less understood by most consumers — hold an important place in the prescription drug-pricing pipeline. In this video, Kaiser Health News details the emergence of these multimillion-dollar corporations and the impact they have on medication costs and patients’ access to these treatments.
Recent Posts
-
Negotiated drug prices would force LTC pharmacists out of business, cost taxpayers billions, coalition says
If Congress does not pass proposed legislation to address the cost to long-term pharmacies related to negotiated drug prices, it could cost taxpayers up to $4.8 billion in increased healthcare costs over the next decade, the Senior Care Pharmacy Coalition said this week.
-
Op-ed: Long-term care pharmacies matter to rural Idaho
Access to health care in rural Idaho is critical, which is why I’m concerned about a serious problem facing our long-term care communities. Because of changes in drug pricing, as of Jan. 1, we may see 60% of America’s long-term care pharmacies close.
-
IRA Drug Supply Fee Bill For LTC Pharmacies Could Prevent $4.8B Cost To Taxpayers
Long-term care (LTC) pharmacies are stepping up their calls for Congress to pass the bipartisan, bicameral Preserving Patient Access to Long-Term Care Pharmacies Act with the release of a new analysis Monday (Nov. 17) by the Senior Care Pharmacy Coalition (SCPC) that found failure to ensure LTC pharmacies are not negatively impacted when new maximum fair prices for select Medicare Part D drugs become effective next year may cost taxpayers up to $4.8 billion in increased health care costs over the next decade.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.